(lp0
S'Verastem to Present at the Oppenheimer 27th Annual Healthcare Conference Yahoo Finance - 14 hours ago Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21st at 2:10 p.m. ET at the Westin Grand&nbsp;...Broker Outlook For The Week Ahead Verastem, Inc.  - Fiscal StandardIs There a Catalyst Out There For Verastem, Inc.  - Morgan Research'
p1
aS'Trading View on Shares of Verastem Inc  Rives Journal - 15 hours ago Technical Traders may be interested in looking at the indicator levels on shares of Verastem Inc . The 14-day ADX for Verastem Inc  is currently 29.93. In general, an ADX value from 0-25 would signal an absent or weak trend. A level of 25 ...'
p2
aS'Verastem Inc. MarketWatch - Jan 27, 2012 Verastem Inc. NASDAQ: VSTM. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p3
aS'Verastem shares plunge as drug trial fails The Boston Globe - Sep 28, 2015 Shares of Verastem Inc. plummeted 67.4 percent Monday after the Cambridge biotech reported that its lead drug candidate failed to help patients suffering from a rare form of lung cancer.Verastem stops cancer therapy development; shares plunge - ReutersVerastem Stops Enrollment Due to Futility in the COMMAND Study of VS-6063 for ... - Business Wire '
p4
aS"Earnings Clues on Innoviva, Inc. , Verastem, Inc.  Analyst's ... StockNewsJournal - Mar 14, 2017 Verastem, Inc. , maintained return on investment for the last twelve months at -37.47, higher than what Reuters data shows regarding industry's average.analysts Recommendations: Verastem, Inc.  - News OracleStock On the Run: Verastem, Inc.  - HugoPress"
p5
aS'Verastem, Inc.  held by 17 SEC 13F Filers Post Analyst - 1 hour ago Verastem, Inc.  reached 30.48% versus a 1-year low price of $1.05. The stock was last seen -11.04% lower, reaching at $1.37 on Mar. 14, 2017.Should You Buy Or Sell Verastem, Inc.  On Analyst Concensus? - NewsDen'
p6
aS'Technical Clues For Verastem, Inc.  Investors USA Commerce Daily - Mar 14, 2017 With all other things going on, Verastem, Inc.  has been on a run - rising 32.76 percent in just three months.'
p7
aS'Buy or Sell Nabors Industries Ltd.  Verastem, Inc. (NASDAQ:VSTM ... Sherwood Daily - 19 hours ago Equity Research firms currently have a positive stance on shares of Nabors Industries Ltd. . The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00.'
p8
aS'Verastem to Present at the 29th Annual ROTH Conference Yahoo Finance - Mar 7, 2017 Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the 29th Annual ROTH Conference on Monday, March 13th at 4:00 p.m. PT at the Ritz Carlton in Dana Point, CA.'
p9
aS'Verastem Names Gregory I. Berk, MD as Chief Medical Officer Business Wire  - Apr 18, 2016 BOSTON----Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced the appointment of Gregory I. Berk, MD as Chief Medical Officer.'
p10
a.